Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Concordia University

$35,000.00

Synthesis and investigation of modified oligonucleotides as probes of DNA repair

EF 2013-14

Résumé
Interstrand cross-links (ICL) can be formed in DNA as a result of endogenous processes such as lipid peroxidation and represent some of the most toxic lesions encountered by cells because they obstruct unwinding of the two strands of DNA which is critical to the processes of replication, transcription and recombination. Interference with these events in the cell by ICLs can be exploited in cancer chemotherapy regimens that employ bifunctional alkylating agents. However, the potency of these agents is diminished by the ability of cancer cells to repair the same lesions these agents induce and this causes the onset of resistance. A number of DNA repair pathways exist in cells including direct repair, base-excision repair, nucleotide-excision repair (NER), homologous recombination (HR), nonhomologous end joining and DNA-mismatch repair. Repair pathways such as NER, HR and translesion DNA synthesis (TLS) have all been implicated in ICL repair in mammalian cells, however, there is an increasing realization that ICL processing may depend on the nature of the lesion (atoms attached, linker length and orientation) making it challenging to generalize how specific ICLs are repaired. A detailed understanding of the processes by which DNA damage are recognized and repaired may lead to the design of more effective alkylating therapeutics that induce lesions that can evade repair. Our group has developed methods using a combination of solution and solid-phase synthesis to prepare sufficient quantities of ICL containing oligonucleotides for biophysical, structural and repair studies. These studies will assess whether such lesions induce a structural change in DNA that may play a role in recognition by repair enzymes. In addition, these ICL DNA will be used in experiments with DNA repair proteins to observe whether these ICL are either susceptible or evade repair processes. Correlations made between structure and repair susceptibility will aid our understanding of the processing of these therapeutically relevant lesions and will contribute to the field of DNA repair.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
299384-2011
Name nom
Wilds, Christopher
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
3
Nb partie
5
Application title
Synthesis and investigation of modified oligonucleotides as probes of DNA repair
Keyword
NSERC
Application summary
Interstrand cross-links (ICL) can be formed in DNA as a result of endogenous processes such as lipid peroxidation and represent some of the most toxic lesions encountered by cells because they obstruct unwinding of the two strands of DNA which is critical to the processes of replication, transcription and recombination. Interference with these events in the cell by ICLs can be exploited in cancer chemotherapy regimens that employ bifunctional alkylating agents. However, the potency of these agents is diminished by the ability of cancer cells to repair the same lesions these agents induce and this causes the onset of resistance. A number of DNA repair pathways exist in cells including direct repair, base-excision repair, nucleotide-excision repair (NER), homologous recombination (HR), nonhomologous end joining and DNA-mismatch repair. Repair pathways such as NER, HR and translesion DNA synthesis (TLS) have all been implicated in ICL repair in mammalian cells, however, there is an increasing realization that ICL processing may depend on the nature of the lesion (atoms attached, linker length and orientation) making it challenging to generalize how specific ICLs are repaired. A detailed understanding of the processes by which DNA damage are recognized and repaired may lead to the design of more effective alkylating therapeutics that induce lesions that can evade repair. Our group has developed methods using a combination of solution and solid-phase synthesis to prepare sufficient quantities of ICL containing oligonucleotides for biophysical, structural and repair studies. These studies will assess whether such lesions induce a structural change in DNA that may play a role in recognition by repair enzymes. In addition, these ICL DNA will be used in experiments with DNA repair proteins to observe whether these ICL are either susceptible or evade repair processes. Correlations made between structure and repair susceptibility will aid our understanding of the processing of these therapeutically relevant lesions and will contribute to the field of DNA repair.